Impact of VIP and cAMP on the regulation of TNF-alpha and IL-10 production: implications for rheumatoid arthritis.

Impact of VIP and cAMP on the regulation of TNF-alpha and IL-10 production: implications for rheumatoid arthritis.

Vasoactive intestinal peptide (VIP) is an anti-inflammatory immunomodulatory neuropeptide with therapeutic potential demonstrated for collagen-induced arthritis. The aim of this study was to characterise its potential anti-arthritic effect on human monocytes, macrophages, T cells, and rheumatoid art...

Full description

Bibliographic Details
Main Authors:	Foey, A, Field, S, Ahmed, S, Jain, A, Feldmann, M, Brennan, F, Williams, R
Format:	Journal article
Language:	English
Published:	BioMed Central 2003

Similar Items

The role of TNF alpha and IL-1 in rheumatoid arthritis.
by: Feldmann, M, et al.
Published: (2001)

Targeting TNF alpha for the therapy of rheumatoid arthritis.
by: Maini, R, et al.
Published: (1994)

TNF alpha--a pivotal role in rheumatoid arthritis?
by: Brennan, F, et al.
Published: (1992)

TNF-alpha in rheumatoid arthritis and prospects of anti-TNF therapy.
by: Maini, R, et al.
Published: (1993)

TNF alpha is an effective therapeutic target for rheumatoid arthritis.
by: Feldmann, M, et al.
Published: (1995)

TNF alpha as a therapeutic target in rheumatoid arthritis.
by: Feldmann, M, et al.
Published: (1994)

TNF blockade in rheumatoid arthritis: implications for therapy and pathogenesis.
by: Maini, R, et al.
Published: (1997)

CD40 ligation induces macrophage IL-10 and TNF-alpha production: differential use of the PI3K and p42/44 MAPK-pathways.
by: Foey, A, et al.
Published: (2001)

Cytokine-stimulated T cells induce macrophage IL-10 production dependent on phosphatidylinositol 3-kinase and p70S6K: implications for rheumatoid arthritis.
by: Foey, A, et al.
Published: (2002)

Regulation of monocyte IL-10 synthesis by endogenous IL-1 and TNF-alpha: role of the p38 and p42/44 mitogen-activated protein kinases.
by: Foey, A, et al.
Published: (1998)

Beneficial effects of tumour necrosis factor-alpha (TNF-alpha) blockade in rheumatoid arthritis (RA)
by: Maini, R, et al.
Published: (1995)

ANTI TNF THERAPY IN RHEUMATOID ARTHRITIS
by: Feldmann, M, et al.
Published: (2011)

Evaluation of the role of cytokines in autoimmune disease: the importance of TNF alpha in rheumatoid arthritis.
by: Feldmann, M, et al.
Published: (1992)

TNFα - A pivotal role in rheumatoid arthritis?
by: Brennan, F, et al.
Published: (1992)

The cytokine network in rheumatoid arthritis: definition of TNF alpha as a therapeutic target.
by: Feldmann, M
Published: (1996)

Anti-TNF alpha therapy of rheumatoid arthritis: what have we learned?
by: Feldmann, M, et al.
Published: (2001)

Contact with T cells modulates monocyte IL-10 production: role of T cell membrane TNF-alpha.
by: Parry, S, et al.
Published: (1997)

Inhibitory effect of TNF alpha antibodies on synovial cell interleukin-1 production in rheumatoid arthritis.
by: Brennan, F, et al.
Published: (1989)

TNF alpha blockade in rheumatoid arthritis: rationale, clinical outcomes and mechanisms of action.
by: Elliott, M, et al.
Published: (1995)

Development of anti-TNF therapy for rheumatoid arthritis.
by: Feldmann, M
Published: (2002)

From the laboratory to the clinic: Evaluation of cytokines in rheumatoid arthritis highlights TNF-alpha as a new therapeutic target
by: Feldmann, M, et al.
Published: (1994)

Discovery of TNF-alpha as a therapeutic target in rheumatoid arthritis: preclinical and clinical studies.
by: Feldmann, M, et al.
Published: (2002)

Cytokine expression and networks in rheumatoid arthritis: rationale for anti-TNF alpha antibody therapy and its mechanism of action.
by: Feldmann, M, et al.
Published: (1995)

Evaluation of TNF-alpha and IL-1 blockade in collagen-induced arthritis and comparison with combined anti-TNF-alpha/anti-CD4 therapy.
by: Williams, R, et al.
Published: (2000)

Neutralizing IL-21 and IL-15 inhibits pro-inflammatory cytokine production in rheumatoid arthritis.
by: Andersson, A, et al.
Published: (2008)

A novel mechanism for TNF-alpha regulation by p38 MAPK: involvement of NF-kappa B with implications for therapy in rheumatoid arthritis.
by: Campbell, J, et al.
Published: (2004)

Anti-TNF alpha therapy in rheumatoid arthritis--current and future directions.
by: Taylor, P, et al.
Published: (2000)

Insights into the pathogenesis of rheumatoid arthritis from application of anti-TNF therapy.
by: Maini, R, et al.
Published: (2000)

Interleukin-10 microsatellite polymorphisms and IL-10 locus alleles in rheumatoid arthritis susceptibility.
by: Eskdale, J, et al.
Published: (1998)

Interleukin 10 (IL-10) haplotypes are associated with rheumatoid arthritis (RA).
by: MacKay, K, et al.
Published: (2000)

Immunoregulatory role of interleukin 10 in rheumatoid arthritis.
by: Katsikis, P, et al.
Published: (1994)

Impact of cAMP on the T-cell response to type II collagen.
by: Ozegbe, P, et al.
Published: (2004)

Rheumatoid arthritis.
by: Feldmann, M, et al.
Published: (1996)

Distribution of IL-10 promoter microsatellite alleles in systemic lupus erythematosus and rheumatoid arthritis.
by: Eskdale, J, et al.
Published: (1996)

Cerebral processing of pain in rheumatoid arthritis patients treated with antiTNF-alpha
by: Wartolowska, K, et al.
Published: (2008)

Anti-TNF biologic agents: still the therapy of choice for rheumatoid arthritis.
by: Taylor, P, et al.
Published: (2009)

Cytokine expression in rheumatoid arthritis.
by: Brennan, F, et al.
Published: (1991)

Anti-IL-12 and anti-TNF antibodies synergistically suppress the progression of murine collagen-induced arthritis.
by: Butler, D, et al.
Published: (1999)

Does bursitis of the forefoot improve in patients with rheumatoid arthritis on anti-TNF-alpha therapy?
by: Bowen, C, et al.
Published: (2007)

Gene expression profiling of treatment response to anti-TNF-alpha therapy in rheumatoid arthritis
by: Meisel, C, et al.
Published: (2004)